carbamazepine has been researched along with Motor Disorders in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Motor Disorders: Motor skills deficits that significantly and persistently interfere with ACTIVITIES OF DAILY LIVING appropriate to chronological age. (from DSM-5)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Machado-Joseph disease (MJD), or spinocerebellar ataxia type 3 (SCA3), is the most common autosomal dominantly-inherited ataxia worldwide and is characterised by the accumulation of mutant ataxin-3 (mutATXN3) in different brain regions, leading to neurodegeneration." | 5.72 | The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease. ( Carmo-Silva, S; Codêsso, JM; França, MC; Martinez, ARM; Nóbrega, C; Pereira de Almeida, L; Silva, P; Vasconcelos-Ferreira, A, 2022) |
| "Machado-Joseph disease (MJD), or spinocerebellar ataxia type 3 (SCA3), is the most common autosomal dominantly-inherited ataxia worldwide and is characterised by the accumulation of mutant ataxin-3 (mutATXN3) in different brain regions, leading to neurodegeneration." | 1.72 | The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease. ( Carmo-Silva, S; Codêsso, JM; França, MC; Martinez, ARM; Nóbrega, C; Pereira de Almeida, L; Silva, P; Vasconcelos-Ferreira, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vasconcelos-Ferreira, A | 1 |
| Carmo-Silva, S | 1 |
| Codêsso, JM | 1 |
| Silva, P | 1 |
| Martinez, ARM | 1 |
| França, MC | 1 |
| Nóbrega, C | 1 |
| Pereira de Almeida, L | 1 |
1 other study available for carbamazepine and Motor Disorders
| Article | Year |
|---|---|
The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.
Topics: Animals; Ataxin-3; Autophagy; Carbamazepine; Humans; Machado-Joseph Disease; Mice; Motor Disorders; | 2022 |